Related Experiment Video
Updated: Apr 14, 2026
08:17
Optical Coherence Tomography: Imaging Mouse Retinal Ganglion Cells In Vivo
Published on: September 22, 2017
20.4K
Precision of the retinal tomograph as a screening device
C Bergin1, J Oleszczuk1, E Sharkawi1
1Department of Ophthalmology, University of Lausanne, Jules-Gonin Eye Hospital, Foundation Asile des Aveugles, Lausanne, Switzerland.
Klinische Monatsblatter Fur Augenheilkunde
|April 23, 2015
Summary
The Heidelberg Retinal Tomograph 3 (HRT3) shows limited accuracy as a sole screening device for eye conditions. Further research is needed to determine its diagnostic utility when compared to standard automated perimetry and clinical exams.
Area of Science:
- Ophthalmology
- Medical Imaging
- Diagnostic Accuracy
Background:
- Glaucoma screening is crucial for early detection and intervention.
- Standard automated perimetry (SAP) and clinical examination are established diagnostic methods.
- Novel imaging technologies are continuously evaluated for their screening potential.
Purpose of the Study:
- To evaluate the diagnostic accuracy of the Heidelberg Retinal Tomograph 3 (HRT3) as a screening tool.
- To compare HRT3 performance against the combined reference standard of Octopus standard automated perimetry (SAP) and clinical findings.
Main Methods:
- Participants underwent HRT3 screening and comprehensive eye examinations within a single day.
- Abnormal HRT3 results were defined by Moorfields Classification (MFC) (borderline or outside normal limits).
- Abnormal SAP and clinical findings included specific criteria for visual field defects, intraocular pressure, cup-to-disc ratio, and optic nerve head appearance.
Main Results:
- The HRT3 demonstrated a sensitivity of 30% and a specificity of 58% in identifying abnormal cases.
- Out of 23 subjects abnormal by SAP and clinical exam, only seven were flagged by the HRT3.
- A significant portion of HRT3 borderline/abnormal results did not correlate with established diagnostic criteria.
Conclusions:
- The HRT3, when used alone, may not be sufficiently accurate for widespread screening of eye diseases.
- Further investigation is warranted to explore the role of HRT3 in conjunction with other diagnostic modalities.
- The current study suggests limitations in HRT3's standalone diagnostic capability for glaucoma screening.
